AG寔繁郊圭

STOCK TITAN

BOTOX速 Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring AG寔繁郊圭 People and Their Distinctive Stories

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Negative)
Tags

AbbVie's (NYSE:ABBV) subsidiary Allergan Aesthetics has launched its largest-ever marketing campaign for BOTOX速 Cosmetic titled 'The One & Only.' The campaign showcases real patients and their unique stories across multiple media channels including TV, digital, and out-of-home advertising.

As the #1 selling neurotoxin worldwide, BOTOX速 Cosmetic has achieved significant milestones with over 100 million vials sold globally and maintains the most FDA-approved aesthetic indication areas in its category. Market research indicates strong customer satisfaction, with 77% of treated consumers considering it worth the cost and 91% of patients expressing intent to continue treatment.

The product recently received recognition as 'Best Injectable' in the 2025 Cosmopolitan Readers' Choice Beauty Awards and continues to be the most trusted choice among aesthetic providers, with 95% of specialists choosing it for themselves, friends, and family.

La controllata di AbbVie (NYSE:ABBV), Allergan Aesthetics, ha lanciato la sua campagna pubblicitaria pi湛 ampia di sempre per BOTOX速 Cosmetic, intitolata 束The One & Only損. La campagna mette in luce persone reali e le loro storie individuali attraverso pi湛 canali media, tra cui TV, digitale e affissioni.

In qualit di neurotossina pi湛 venduta al mondo, BOTOX速 Cosmetic ha raggiunto traguardi importanti con oltre 100 milioni di fiale vendute a livello globale e mantiene il maggior numero di approvazioni FDA per indicazioni estetiche nella sua categoria. Le ricerche di mercato mostrano unelevata soddisfazione: il 77% dei consumatori trattati ritiene che valga il costo e il 91% dei pazienti dichiara lintenzione di proseguire i trattamenti.

Il prodotto 竪 stato recentemente riconosciuto come 束Best Injectable損 nei Cosmopolitan Readers' Choice Beauty Awards 2025 e rimane la scelta pi湛 affidabile tra i professionisti dellestetica, con il 95% degli specialisti che lo preferisce per s辿, amici e familiari.

La filial de AbbVie (NYSE:ABBV), Allergan Aesthetics, ha lanzado su mayor campa単a de marketing hasta la fecha para BOTOX速 Cosmetic, titulada 束The One & Only損. La campa単a presenta a pacientes reales y sus historias 炭nicas a trav辿s de m炭ltiples canales medi叩ticos, incluyendo TV, digital y publicidad exterior.

Como la neurotoxina n炭mero 1 en ventas a nivel mundial, BOTOX速 Cosmetic ha alcanzado hitos significativos con m叩s de 100 millones de viales vendidos globalmente y mantiene la mayor cantidad de indicaciones est辿ticas aprobadas por la FDA en su categor鱈a. Las investigaciones de mercado indican una s坦lida satisfacci坦n del cliente: el 77% de los consumidores tratados considera que merece el coste y el 91% de los pacientes manifiesta la intenci坦n de continuar el tratamiento.

El producto fue recientemente reconocido como 束Best Injectable損 en los Cosmopolitan Readers' Choice Beauty Awards 2025 y sigue siendo la opci坦n de mayor confianza entre los profesionales est辿ticos, con un 95% de especialistas que lo eligen para s鱈 mismos, amigos y familiares.

AbbVie's(NYSE:ABBV) Allergan Aesthetics螳仰 BOTOX速 Cosmetic� 豕 襷貅� 貂� The One & Only襯 給. 企 貂語 TV, 讌�, レ 蟯螻 � れ� 襷れ牡襯� 牛 れ り骸 蠏碁れ� 螻� ろ襴襯 覲伎譴�.

� 瑚 襷 1� 蟆暑� BOTOX速 Cosmetic � 瑚 1� 覲� 伎 襷朱 譴� 伎襯 燕朱�, 企 豺危螻襴 螳仰� 襷 FDA 轟 覩語 讀 覲伎螻 給. 譟一� 磯ゴ覃� 螻螳 襷譟焔螳� 豺襭覦 觜 77%螳仰 觜 觜� 螳仰豺螳� り� 螳仰朱, � 91%� 豺襭襯� 螻� レ� り� 牛給.

� 豕蠏 2025 Cosmopolitan Readers' Choice Beauty Awards Best Injectable襦 螻�, 覩語 螻旧 伎 螳仰� 襤磯 朱 朱� 覓瑚斡底� 95%螳仰 覲語瑚� 豺蟲揃螳仰譟煙蟆� 蟠り 牛給�.

La filiale dAbbVie (NYSE:ABBV), Allergan Aesthetics, a lanc辿 sa plus grande campagne marketing ce jour pour BOTOX速 Cosmetic, intitul辿e 束 The One & Only 損. La campagne met en avant de vrais patients et leurs histoires singuli竪res travers plusieurs m辿dias, dont la TV, le digital et laffichage ext辿rieur.

En tant que neurotoxine la plus vendue au monde, BOTOX速 Cosmetic a franchi des 辿tapes importantes avec plus de 100 millions de flacons vendus l辿chelle mondiale et d辿tient le plus grand nombre dindications esth辿tiques approuv辿es par la FDA dans sa cat辿gorie. Les 辿tudes de march辿 montrent une forte satisfaction client : 77 % des consommateurs trait辿s estiment que le co短t en vaut la peine et 91 % des patients ont lintention de poursuivre le traitement.

Le produit a r辿cemment 辿t辿 辿lu 束 Best Injectable 損 lors des Cosmopolitan Readers' Choice Beauty Awards 2025 et demeure le choix le plus fiable parmi les praticiens esth辿tiques, 95 % des sp辿cialistes le recommandant pour eux-m棚mes, leurs amis et leur famille.

Die Tochtergesellschaft von AbbVie (NYSE:ABBV), Allergan Aesthetics, hat ihre bisher gr旦te Marketingkampagne f端r BOTOX速 Cosmetic mit dem Titel The One & Only� gestartet. Die Kampagne zeigt echte Patientinnen und Patienten und ihre pers旦nlichen Geschichten 端ber mehrere Medienkan辰le, darunter TV, Digital und Auenwerbung.

Als weltweit meistverkauftes Neurotoxin hat BOTOX速 Cosmetic bedeutende Meilensteine erreicht, mit 端ber 100 Millionen verkauften Ampullen weltweit, und verf端gt 端ber die meisten FDA-zugelassenen 辰sthetischen Indikationen in seiner Kategorie. Marktforschungen zeigen hohe Kundenzufriedenheit: 77 % der behandelten Konsumenten halten die Behandlung f端r ihr Geld wert und 91 % der Patienten beabsichtigen, die Behandlung fortzusetzen.

Das Produkt wurde k端rzlich bei den 2025 Cosmopolitan Readers' Choice Beauty Awards als Best Injectable� ausgezeichnet und bleibt die vertrauensw端rdigste Wahl unter 辰sthetischen Anbietern, wobei 95 % der Spezialisten es f端r sich selbst sowie f端r Freunde und Familie w辰hlen.

Positive
  • Market leadership position as #1 selling neurotoxin worldwide
  • Strong customer satisfaction with 77% considering it worth the cost
  • High retention rate with 91% of patients planning to continue treatment
  • 95% of specialists choose it for themselves, friends, and family
  • Over 100 million vials sold globally
  • Most FDA-approved aesthetic indication areas in its category
Negative
  • None.
  • Building on the brand's 20-year legacy and real-world experience, the original BOTOX Cosmetic continues to be the most researched and requested product of its kind.1,2
  • BOTOX速 Cosmetic is trusted by aesthetic providers with 95% of specialists choosing it for themselves, their friends, and family.3
  • This campaign is BOTOX Cosmetic's largest ever, appearing across national linear and connected TV, digital, social, and out-of-home.

IRVINE, Calif., Sept. 9, 2025 /PRNewswire/ --油Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced a new chapter for with the debut of "The One & Only" campaign, a national, multichannel marketing initiative that champions self-expression and individuality. The one and only brand to do it first, BOTOX Cosmetic is the #1 selling neurotoxin worldwide with the most FDA-approved aesthetic indication areas in the category, empowering patients to embrace the one and only version of themselves.2,4-9

The One & Only campaign features real, everyday people, both new and repeat patients, treated with BOTOX Cosmetic. The campaign depicts each person doing what they love, while showing off their individuality. The One & Only campaign demonstrates that patients are their same unique selves, even after treatment. The tagline for the campaign is, "The one & only BOTOX Cosmetic. The one & only you."

"Just as each person is distinct, so too are their aesthetic goals. As a champion of authenticity, Allergan Aesthetics' new campaign features real people, not actors, who rely on BOTOX Cosmetic's precise, predictable results," said Glen Curran, Senior Vice President, U.S., Allergan Aesthetics. "When it comes to being yourself and choosing treatment with BOTOX Cosmetic, there's no substitute for the real thing. The one and only BOTOX Cosmetic continues to empower patients throughout their treatment journey."

BOTOX Cosmetic is the product patients ask for by name and tell others about, with market research showing that 77 percent of treated consumers believe it is worth the cost.11* It is also the product patients keep coming back for; 91 percent of patients say they will continue using BOTOX Cosmetic if their specialist says they are right for treatment.12�Additionally,油Cosmopolitan magazine recently recognized BOTOX Cosmetic as "Best Injectable" in the 2025 Cosmopolitan Readers' Choice Beauty Awards, with readers saying, "BOTOX Cosmetic continues to be the one you depend on; it's the one and only."

FDA-approved for more than 20 years, BOTOX Cosmetic continues to lead the market with more than 100 million vials sold globally.4,10 The brand has four FDA-approved aesthetic indication areas, the most in the category, including moderate to severe frown lines, crow's feet lines, forehead lines, and vertical bands connecting the neck and jaw (platysma bands) in adults.4

The One & Only campaign will run across national linear and connected television, digital, social, and out-of-home. Those interested in learning more about BOTOX Cosmetic and The One & Only campaign can visit 油and enroll in油, the leading aesthetics loyalty program from Allergan Aesthetics.油

*Based on a 2023 online survey of 233 BOTOX Cosmetic users.11

Based on a 2023 online survey of 258 BOTOX Cosmetic users who strongly or somewhat agreed they would continue receiving BOTOX Cosmetic treatment.12

About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit .

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas � immunology, oncology, neuroscience, and eye care � and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

IMPORTANT SAFETY INFORMATION

BOTOX油Cosmetic may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX油Cosmetic:

  • Problems swallowing, speaking, or breathing,油due to weakening of associated muscles, which can be severe and result in loss of life. You are at the highest risk if these problems are preexisting before injection. Swallowing problems may last for several months.油
  • Spread of toxin effects.油The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms, including loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, and trouble swallowing.油

BOTOX油Cosmetic dosing units are not the same as, or comparable to, any other botulinum toxin product.

There has not been a confirmed serious case of spread of toxin effect when BOTOX Cosmetic has been used at the recommended dose to treat frown lines, crow's feet lines, forehead lines, and/or platysma bands.油

BOTOX Cosmetic may cause loss of strength or general muscle weakness, vision problems, or dizziness within hours to weeks of receiving BOTOX Cosmetic. If this happens, do not drive a car, operate machinery, or do other dangerous activities.

Serious and/or immediate allergic reactions have been reported, including itching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or feeling faint. Get medical help right away if you are wheezing or have asthma symptoms, or if you become dizzy or faint.油

Do not receive BOTOX油Cosmetic if you油are allergic to any of the ingredients in BOTOX Cosmetic (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc (rimabotulinumtoxinB), Dysport (abobotulinumtoxinA), Xeomin (incobotulinumtoxinA), Jeuveau (prabotulinumtoxinA-xvfs), Daxxify (daxibotulinumtoxinA-lanm), or Letybo (letibotulinumtoxinA-wlbg); or have a skin infection at the planned injection site. This list may not include all available botulinum toxin products.油

Tell your doctor about all your muscle or nerve conditions,油such as ALS or Lou Gehrig's disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects, including difficulty swallowing and difficulty breathing, from standard doses of BOTOX Cosmetic.油

Tell your doctor about all your medical conditions,油including surgery or plans to have surgery on your face, trouble raising your eyebrows, drooping eyelids, any other abnormal facial change, are pregnant or plan to become pregnant (it is not known if BOTOX Cosmetic can harm your unborn baby), or are breastfeeding or plan to (it is not known if BOTOX Cosmetic passes into breast milk).油

Tell your doctor about all the medicines you take,油including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX Cosmetic with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received BOTOX Cosmetic in the past.

Tell your doctor if you have received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc, Dysport, Xeomin, Jeuveau, Daxxify, or Letybo in the past (tell your doctor exactly which product you received); have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; take a sleep medicine; or take aspirin-like products or blood thinners.油

Other side effects of BOTOX油Cosmetic include油dry mouth; discomfort or pain at the injection site; tiredness; headache; neck pain; and eye problems, including double vision, blurred vision, decreased eyesight, drooping eyelids and eyebrows, swelling of eyelids, and dry eyes.油

For more information, refer to the Medication Guide or talk with your doctor.油

To report a side effect, please call Allergan Aesthetics at 1-800-678-1605.油

Please see BOTOX油Cosmetic full油, including Boxed Warning and油.

References:

  1. Data on File. Allergan, Botulinum Toxin Peer-Reviewed Publications, January 2024.
  2. Data on File. AbbVie, Neurotoxin Monthly Tracker Report, January 2025.
  3. Data on File. Allergan, Choosing Botox Quick Quant Study, July 2023
  4. BOTOX Cosmetic Prescribing Information, October 2024.
  5. Dysport Prescribing Information, September 2023.
  6. Xeomin Prescribing Information, July 2024.
  7. Jeuveau Prescribing Information, April 2023.
  8. Daxxify Prescribing Information, November 2023.
  9. Letybo Prescribing Information, February 2024
  10. Data on File, Total Number of BOTOX Vials, December 2022
  11. Data on File. Allergan, Neurotoxin Facial Injectables Consumer A&U, 2024.
  12. Data on File. Allergan, BOTOX Cosmetic Claims Assessment, April 2023.

Contact(s)

Investors:
Liz Shea
[email protected]
(847) 935-2211

Media:
Ember Garrett
[email protected]
(714) 246-3525

息 2025 AbbVie. All rights reserved. BOTOX Cosmetic and its designs are trademarks of Allergan Holdings France SAS, and AbbVie company, or its affiliates. All other trademarks are the property of their respective owners.

Cision View original content to download multimedia:

SOURCE AbbVie

FAQ

What is AbbVie's new 'The One & Only' BOTOX速 Cosmetic campaign about?

The campaign is AbbVie's largest-ever marketing initiative for BOTOX速 Cosmetic, featuring real patients and their unique stories across national TV, digital, social, and out-of-home advertising channels.

How many BOTOX速 Cosmetic vials have been sold globally by AbbVie (ABBV)?

BOTOX速 Cosmetic has sold over 100 million vials globally and is the #1 selling neurotoxin worldwide.

What percentage of specialists choose BOTOX速 Cosmetic for themselves and family?

95% of aesthetic specialists choose BOTOX速 Cosmetic for themselves, their friends, and family members.

What are the FDA-approved aesthetic indication areas for BOTOX速 Cosmetic?

BOTOX速 Cosmetic has four FDA-approved aesthetic indication areas: moderate to severe frown lines, crow's feet lines, forehead lines, and vertical bands connecting the neck and jaw (platysma bands) in adults.

What is the patient satisfaction rate for BOTOX速 Cosmetic treatments?

According to market research, 77% of treated consumers believe BOTOX速 Cosmetic is worth the cost, and 91% of patients say they will continue using it if their specialist recommends it.
Abbvie Inc

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Latest SEC Filings

ABBV Stock Data

370.61B
1.76B
0.1%
74.56%
0.86%
Drug Manufacturers - General
Pharmaceutical Preparations
United States
NORTH CHICAGO